Article Versions Notes

Chan H-C, Ke L-Y, Lu H-T, Weng S-F, Chan H-C, Law S-H, Lin I-L, Chang C-F, Lu Y-H, Chen C-H, et al. An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease. Biomedicines. 2020; 8(12):542. https://doi.org/10.3390/biomedicines8120542

Chan, Hua-Chen, Liang-Yin Ke, Hsiao-Ting Lu, Shih-Feng Weng, Hsiu-Chuan Chan, Shi-Hui Law, I-Ling Lin, Chuan-Fa Chang, Ye-Hsu Lu, Chu-Huang Chen, and et al. 2020. "An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease" Biomedicines 8, no. 12: 542. https://doi.org/10.3390/biomedicines8120542

Chan, H.-C., Ke, L.-Y., Lu, H.-T., Weng, S.-F., Chan, H.-C., Law, S.-H., Lin, I.-L., Chang, C.-F., Lu, Y.-H., Chen, C.-H., & Chu, C.-S. (2020). An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease. Biomedicines, 8(12), 542. https://doi.org/10.3390/biomedicines8120542